当前位置: 首页 > 期刊 > 《医学信息》 > 2019年第18期
编号:13423893
糖耐量异常患者血清癌胚抗原相关细胞黏附分子1与动脉粥样硬化的关系(4)
http://www.100md.com 2019年5月7日 《医学信息》 2019年第18期
     [9]Xu Y,Wang L,He J,et al.Prevalence and control of diabetes in Chinese adults[J].JAMA,2013,310(9):948-959.

    [10]Friedrich SK,Lang PA,Friebus-Kardash J,et al.Mechanisms of lymphatic system-specific viral replication and its potential role in autoimmune disease[J].Clinical and Experimental Immunology,2019,195(1):64-73.

    [11]Nagaishi T,Iijima H,Nakajima A,et al. Role of CEACAM1 as a regulator of T cells[J].Ann N Y Acad Sci,2006(1072):155-175.

    [12]Weiner GM,Ducruet AF.CEACAM1:a novel adhesion molecule that regulates the secretion of matrix metalloproteinase-9 in neutrophils and protects the blood-brain barrier after ischemic stroke[J].Neurosurgery,2014,75(4):N21-N22.

    [13]Wang Y,Chen Y,Yan Y,et al.Loss of ceacam1,a tumor-associated factor,attenuates post-infarction cardiac remodeling by inhibiting apoptosis[J].Scientific Reports,2016(6):21972.

    [14]DeAngelis AM,Heinrich G,Dai T,et al.Carcinoembryonic antigen-related cell adhesion molecule 1:A link between insulin and lipid metabolism[J].Diabetes,2008,57(9):2296-2303.

    [15]張凤丽,何立娟,崔清华,等.血清胎球蛋白A水平对糖耐量减低的预测价值[J].疑难病杂志,2018,17(5):464-467.

    收稿日期:2019-4-25;修回日期:2019-5-28

    编辑/杜帆, http://www.100md.com(汪艳 杨俊 段会仙)
上一页1 2 3 4